Compare AKBA & CYH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AKBA | CYH |
|---|---|---|
| Founded | 2007 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Hospital/Nursing Management |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 375.0M | 432.2M |
| IPO Year | 2014 | 2000 |
| Metric | AKBA | CYH |
|---|---|---|
| Price | $1.01 | $2.78 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 3 | 6 |
| Target Price | ★ $4.67 | $3.28 |
| AVG Volume (30 Days) | ★ 5.0M | 1.8M |
| Earning Date | 05-07-2026 | 04-21-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 93.94 | ★ 196.67 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $12,485,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $2.17 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.88 | $2.39 |
| 52 Week High | $4.08 | $4.43 |
| Indicator | AKBA | CYH |
|---|---|---|
| Relative Strength Index (RSI) | 34.96 | 43.44 |
| Support Level | N/A | $2.41 |
| Resistance Level | $1.56 | $2.81 |
| Average True Range (ATR) | 0.08 | 0.11 |
| MACD | -0.03 | 0.00 |
| Stochastic Oscillator | 19.55 | 29.51 |
Akebia Therapeutics Inc is a fully integrated biopharmaceutical company. The Company's operating segment is the business of developing and commercializing novel therapeutics. The current portfolio of the company includes Auryxia (ferric citrate), a medicine approved and marketed in the United States for the control of serum phosphorus levels in adult patients with dialysis-dependent chronic kidney disease and the treatment of iron deficiency anemia, in adult patients with non-dialysis-dependent chronic kidney disease, Vafseo (vadadustat), an oral hypoxia-inducible factor prolyl hydroxylase, inhibitor approved in Japan for the treatment of anemia due to chronic kidney disease, and HIF-PH inhibitors in preclinical development.
Community Health Systems Inc is a publicly owned hospital operator in the United States. The company also owns four home health agencies and provides management and consulting services to independent hospitals. The firm derives revenue through a broad range of general and specialized hospital healthcare services and outpatient services.